Wieder, Cecilia
Liedl, Eloisa Rocha
Payne, Thomas
Yurekten, Ozgur
Martin, Callum
Amaladoss, Felix Xavier
Tejera, Noemi
Lin, Wanchang
Abiead, Yasin El
Dorrestein, Pieter
O’Donovan, Claire
Vizcaíno, Juan Antonio
Dunn, Warwick
Ebbels, Timothy
Funding for this research was provided by:
Biotechnology and Biological s (BB/W002345/1)
Biotechnology and Biological s (BB/W002345/1)
Biotechnology and Biological s (BB/W002345/1)
Biotechnology and Biological s (BB/W002345/1)
Biotechnology and Biological s (BB/W002345/1)
Biotechnology and Biological s (BB/W002345/1)
Biotechnology and Biological s (BB/W002345/1)
Biotechnology and Biological s (BB/W002345/1)
Biotechnology and Biological s (BB/W002345/1)
Biotechnology and Biological s (BB/W002345/1)
Biotechnology and Biological s (BB/W002345/1)
Biotechnology and Biological s (BB/W002345/1)
National Science Foundation (DBI-2152526)
National Science Foundation (DBI-2152526)
Österreichische Akademie der Wissenschaften (APART-USA)
Biotechnology and Biological Sciences Research Council (BB/T007974/1)
Biotechnology and Biological Sciences Research Council (BB/W000156/1)
Biotechnology and Biological Sciences Research Council (BB/T007974/1)
Biotechnology and Biological Sciences Research Council (BB/T007974/1)
Chan Zuckerberg Initiative (2024-350548)
European Molecular Biology Laboratory (Core Funding)
European Commission (EC101079370)
UK Research and Innovation (10050966)
Article History
Received: 1 April 2026
Accepted: 3 July 2026
First Online: 15 July 2026
Declarations
Competing interests: The authors declare no competing interests.
Research involving human and animal participants: This article does not contain any studies with human and/or animal participants performed by any of the authors.